IL6 and neoplasm: Urinary IL-8 has been considered a potential prognostic factor for tumor recurrence and progression following BCG therapy (31), while decreased IL-6 serum levels in patients with bladder cancer correlate with the appearance of myeloid-derived suppressor cells and poor prognosis (32).